Status:
COMPLETED
Safety and Tolerability of Retinoid QLT091001 in Healthy Volunteers
Lead Sponsor:
QLT Inc.
Conditions:
Healthy Human Volunteers
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
Brief Summary
Healthy volunteer subjects will receive retinoid QLT091001 once-daily for 7 days for safety observation.
Eligibility Criteria
Inclusion
- Healthy subjects with ECG within normal limits and normal blood pressure and resting heart rate
Exclusion
- Subjects with any clinically important abnormal physical finding at screening.
- Subjects who are actively participating in an experimental therapy study or who have received experimental therapy within 60 days of baseline.
- Female subjects who are either pregnant or lactating.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2009
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00765427
Start Date
September 1 2008
End Date
March 1 2009
Last Update
March 30 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto, Ontario, Canada